Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PT435 – The Federal Right to Try Act, The Farm Bill,...

Sunstone Therapies in Collaboration with the University of Vermont Announces Publication...

GH Research Reports Second Quarter 2023 Financial Results and Provides Business...

PT434 – Kiyumí Retreats, Building Somatic Literacy, and Navigating Group Facilitation...

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Psyence Group Announces Closing of Private Placement & Conclusion of Loan...

Psychedelic Retreats: The Ultimate Working Vacation

PT433 – From Personal Healing to Public Policy: The Path to...

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined...

MIND CURE HEALTH INC. (TO BE RENAMED LNG ENERGY GROUP CORP.)...

1...495051...218 Page 50 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin